	Prognosis and Treatment Response in Aggressive-variant Prostate Cancer and Treatment-related Neuroendocrine Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol Pedrani M, Salfi G, Pecoraro G, Puglisi M, Turco F, Tortola L, Urechie V, Leone G, Lin HM, Vogl U, Barizzi J, Treglia G, Cuzzocrea M, Paone G, Lai P, Theurillat JP, Zilli T, Gillessen S, Merler S, Pereira Mestre R. PMID: 41672832 [PubMed - as supplied by publisher]
	Intraoperative evaluation of detrusor muscle during transurethral resection of bladder tumour using confocal fluorescent microscopy. BJU Int Soputro NA, Wang L, Daher K, Al-Bayati A, Watfa M, Younis SK, El-Hussein M, Olivares R, Autorino R, Weight CJ, Kaouk J, Nguyen JK, Almassi N. PMID: 41672610 [PubMed - as supplied by publisher]
	The efficacy of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A meta-analysis and reconstructed individual patient data analysis. Hum Vaccin Immunother Zhang F, Xiong Y, Luo Z, Xue Q, Wang L, Fu Q, Zhang W, Alisha PA, Okoli UA, Zhang G. PMID: 41672480 [PubMed - indexed for MEDLINE]
	PSMA PET Imaging in the Postradiotherapy Setting: Implications for the Diagnosis of Recurrent Prostate Cancer. Clin Genitourin Cancer Barragán VV, Couñago F, Pozo NS, Santamaria PW, Ramírez AG, Boronat MG, Gomis-Sellés E, Vicente JS, Campos FL. PMID: 41671998 [PubMed - as supplied by publisher]
	HALP score as an independent prognostic biomarker for recurrence and progression in non-muscle-invasive bladder cancer: A retrospective cohort study. Surg Oncol Utlu A, Aksakall, Çelik F, Cinislio, Altay MS, Bedir F, Kocatürk H, Karabulut . PMID: 41671709 [PubMed - as supplied by publisher]
	The Impact of Race on Survival and Treatment in Veterans Treated for Metastatic Castration-Resistant Prostate Cancer. J Natl Compr Canc Netw Candelieri-Surette D, Cheranda N, Lee J, Teerlink CC, Pimentel C, Lynch JA, Berlowitz D, Schoen MW. PMID: 41671453 [PubMed - indexed for MEDLINE]
	Geographic Variability in Germline Genetic Testing for Prostate Cancer: A Nationwide Medicare Claims Study With Evidence of Low Uptake. J Natl Compr Canc Netw Korn SM, Qian Z, Zurl H, Piccolini A, Pohl KK, Lipsitz SR, Zhang J, Kibel AS, Moore CM, Rana HQ, Kilbridge KL, Shariat SF, Giri VN, Loeb S, Trinh QD, Cole AP. PMID: 41671443 [PubMed - indexed for MEDLINE]
	A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM Study. J Natl Compr Canc Netw Yamoah K, Trivedi P, Awasthi S, Grass GD, Torres-Roca J, Johnstone PA, Dhillon J, Park JY, Davicioni E, Hakansson A, Liu Y, Fink AK, Katende E, Smith R, Putney R, Poch M, Li R, Manley B, Fernandez D, Gage K, Ferguson K, Lu-Yao G, Kim Y, Katsoulakis E, Leone A, Vapiwala N, Deville C, Rebbeck TR, Dicker AP, Kelly W, Yin V, Burri RJ, Ercole CE, Pow-Sang J. PMID: 41671436 [PubMed - indexed for MEDLINE]
	Prostate cancer survival according to socioeconomic and tumor characteristics in Manizales, Colombia. Rev Peru Med Exp Salud Publica Giraldo-Osorio A, Ladino JD, Giraldo Restrepo MÁ, Vargas Dussan LF, Arias-Ortiz N. PMID: 41670103 [PubMed - indexed for MEDLINE]
	Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel. Cancer McKay RR, Maughan BL, Morgans AK, Shore ND, Yu EY, Madan RA, Berchuck JE, Carthon BC, Finkelstein SE, Gomella L, Gorin MA, Hahn AW, Loeb S, Narayan VK, Petrylak DP, Ryan CJ, Tawagi K, Tran PT, Dorff T. PMID: 41669866 [PubMed - indexed for MEDLINE]
	Clinical application of PRIMARY score in diagnosing clinically significant prostate cancer: a comparative study using (68)Ga-PSMA-11 and (18)F-PSMA-1007 positron emission tomography/computed tomography. Quant Imaging Med Surg Xie YJ, Zou Q, Yang T, Hu SQ, Shen ZJ, Chen GF, Li S, Zhang Y. PMID: 41669446 [PubMed]
	Revealing the function and mechanism of piRNA-related genes in bladder cancer through single-cell sequencing and methylation analyses and construction of prognostic features based on consensus clustering. Curr Urol Sun X, Jia D, Song X, Jiang Y, Wu F, Ning H, Lyu J. PMID: 41668898 [PubMed]
	Significant differences in CD276 (B7H3) expression between female and male bladder cancer tissue samples: An exploratory study. Curr Urol Harland N, Reitnauer LE, Amend B, Bahlinger V, Hennenlotter J, Stenzl A, Aicher WK, Walz S. PMID: 41668895 [PubMed]
	Anxiety, Depression, and Suicidality Among Testicular Cancer Survivors. Cancer Med Meagher M, Riviere P, Nelson T, Morgan K, Puri D, Pandit K, Yodkhunnatham N, Yuen K, Taylor J, Herchenhorn D, Stewart T, Javier-Desloges J, Salmasi A, McKay R, Kern S, Millard F, Rose B, Bagrodia A. PMID: 41668134 [PubMed - indexed for MEDLINE]
	Predicting renal-cell carcinoma recurrence after partial nephrectomy: a CT-radiomics approach. Int Urol Nephrol Vovdenko S, Kuznetsov I, Amrakhov S, Chernenkiy M, Chernenkiy I, Proskura A, Zholdubaev A, Ismailov K, Vinogradov A, Fiev D, Sirota E, Shpot E, Alyaev Y, Glybochko P. PMID: 41667901 [PubMed - as supplied by publisher]
	Treatment patterns in patients with castration-resistant prostate cancer who received darolutamide in the ARAMIS trial in Spain: PARASEC study. Clin Transl Oncol Puente J, Campanario R, Marmolejo D, Cantero-Mellado JA, Gómez-Ferrer Á, Rodríguez Antolín A, Ribal MJ, Picola Brau N, Ledo MJ, Hernandez C, Llorente C, González-Enguita C, Bisonó Castillo Á, Benejam J, Gil Guijarro J, Garcia-Sanchez J, Folqué J, Casas-Nebra J. PMID: 41667886 [PubMed - as supplied by publisher]
	Transperineal Versus Transrectal Biopsy for Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Oncol Marra G, Bazzurro F, Dematteis A, Sasia A, Gardois P, Venturi A, Merani U, Calleris G, Marquis A, Oderda M, Matsukawa A, Zugna D, Shariat SF, Ploussard G, Briganti A, Gandaglia G, Rajwa P, Richiardi L, Gontero P. PMID: 41667335 [PubMed - as supplied by publisher]
	Initial Experience With Robot-Assisted Nephroureterectomy Using the Hugo Robot-Assisted Surgery System via a Retroperitoneal Approach: Clinical Comparison With the Transperitoneal Approach. Asian J Endosc Surg Morizane S, Yamamoto A, Yamane H, Nishikawa R, Kimura Y, Yamaguchi N, Hikita K, Ikeda M, Tabata KI, Mukuda T, Kaidoh T, Takenaka A. PMID: 41666941 [PubMed - indexed for MEDLINE]
	Not all PI-RADS 3 lesions are the same: Higher rate of clinically significant prostate cancer among Black men on targeted biopsy in a diverse cohort. Urol Oncol Hanelin DG, Dave P, Baca A, Joseph M, Patel R, Sankin A, Aboumohamed A, Reese S, Agalliu I, Watts K. PMID: 41666650 [PubMed - as supplied by publisher]
	Combination of serum TBL1XR1, MFAP5, and PSA as diagnostic biomarkers for prostate cancer. Clinics (Sao Paulo) Wu X, Lin X, Lin J. PMID: 41666500 [PubMed - as supplied by publisher]

Articles 1 - 20 / 175917

Page 1 of 8796



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy